Beyond Understanding – How Can Cell Therapy Drug Developers Implement New FDA Guidelines?
Time: 4:00 pm
day: Conference Day One
Details:
- Investigating the implications of the FDA’s new potency guidance for cell therapies
- Determining strategies to ensure compliance with evolving potency requirements
- Clarifying the FDA’s emphasis on Critical Quality Attributes (CQAs) for potency assurance
